Travere Therapeutics
$24.959876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$24.95
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.99 (-3.82%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell TVTX and other stocks, options, and ETFs commission-free!
About TVTX
Travere Therapeutics, Inc. Common Stock, also called Travere Therapeutics, is a biopharmaceutical company.
CEO
Eric M. Dube
Employees
262
Headquarters
San Diego, California
Founded
2008
Market Cap
1.45B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
410.27K
High Today
$26.46
Low Today
$24.38
Open Price
$26.23
Volume
690.68K
52 Week High
$33.09
52 Week Low
$13.63
Analyst Ratings
100%
of 9 ratings
Buy
100%
Hold
0%
Sell
0%
TVTX Earnings
-$1.05
-$0.70
-$0.35
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 10, After Hours